JDD October 2023 Issue Highlights | Special Topic: Atopic Dermatitis
182121821218212
The October 2023 issue of the Journal of Drugs in Dermatology (JDD) focuses on atopic dermatitis and features mix of original articles, letters to the editor, and case reports. Among many of the topics explored in this issue are statins for treating actinic porokeratosis, ant venom-based ceramide therapy, the psychosocial burden of skin disease among skin of color consumers, treatment of lichen pl …
The October 2023 issue of the Journal of Drugs in Dermatology (JDD) focuses on atopic dermatitis and features mix of original articles, letters to the editor, and case reports. Among many of the topics explored in this issue are statins for treating actinic porokeratosis, ant venom-based ceramide therapy, the psychosocial burden of skin disease among skin of color consumers, treatment of lichen pl … Continue reading "JDD October 2023 Issue Highlights | Special Topic: Atopic Dermatitis"
Pediatric dermatologic emergencies are very real, highlights Dr. Kalyani Marathe, Associate Professor of Dermatology and Pediatrics at the University of Cincinnati, who lectured during ODAC 2023. Pediatric dermatologic emergencies represent almost 4% of emergency room visits, and of those, most are related to chronic skin disease, drug eruptions, and infections. Here, we will review some of those … 
Psoriasis, a chronic inflammatory skin condition, affects about 2% of children. A small subset have isolated nail involvement refractory to topical treatment that can be disabling. The development of targeted biologic agents offers safe, effective options for children with moderate-to-severe skin and nail disease. A few are now Food and Drug Administration (FDA)-approved for children.
INTRODUCTIO … 
Hair is part of our identity and hair loss is therefore particularly distressing to patients. With so many potential causes of hair loss, our expertise as dermatologists is desperately needed, especially among pediatric patients where hair loss can be even more concerning to patients and their parents. To help us examine, diagnose, and counsel pediatric patients with hair loss, we were lucky to ha … 
Dr. Shari Lipner, Associate Professor of Clinical Dermatology and Director of the Nail Division at Weill Cornell Medicine and President of The Dermatologic Society of Greater New York, shared her expertise of nail disorders in patients with skin of color: from nail psoriasis and onychomycosis to subungual melanoma.
Dr. Lipner’s lecture focused on the following key points (spoiler alert!):
… 